Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DOC2US is a Malaysian digital health and telemedicine company operating a commercial online consultation and electronic prescription platform. The business connects patients with doctors and other healthcare professionals through chat-based teleconsultation, e-prescriptions, medication fulfillment, referral workflows, and related outpatient care services. Its platform is used across consumer, corporate, pharmacy, and insurer-integrated channels, and the company has expanded into broader digital outpatient care navigation, including e-referral and home-based healthcare offerings. DOC2US appears to be operated by HEYDOC International Sdn Bhd and is closely associated with the broader Heydoc Health brand. The company is not a drug developer; it is a healthcare services and software platform business.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DOC2US.